Bausch Health Companies (BHC) Income from Continuing Operations (2009 - 2026)

Bausch Health Companies' (BHC) quarterly Income from Continuing Operations came in at 1431000000.0 in Q1 2026, down 1563.95% year-on-year from 97749007.15 in Q1 2025, and down 1289.32% quarter-over-quarter from 103000000.0 in Q4 2025.

Bausch Health Companies (BHC) Income from Continuing Operations (2009 - 2026) Analysis & Trends

Bausch Health Companies has disclosed Income from Continuing Operations across 18 years of filings, most recently posting 1431000000.0 for Q1 2026.

  • Income from Continuing Operations for Q1 2026 came in at 1431000000.0, down 1563.95% year-over-year; the trailing twelve-month figure through Mar 2026 was 1225000000.0 (down 1412.35% YoY), and the FY2025 annual result was 120000000.0, up 266.67% from the prior year.
  • Income from Continuing Operations came in at 1431000000.0 for Q1 2026 at Bausch Health Companies, down from 103000000.0 in the prior quarter.
  • In the past five years, Income from Continuing Operations ranged from a high of 403000000.0 in Q3 2022 to a low of 1431000000.0 in Q1 2026.
  • The 5-year median for Income from Continuing Operations is 77000000.0 (2024), against an average of 129764705.88.
  • Across the five-year window, Income from Continuing Operations soared 12900.0% in 2025 and slumped 1563.95% in 2026, its largest moves.
  • Bausch Health Companies' Income from Continuing Operations stood at 410000000.0 in 2022, then soared by 88.54% to 47000000.0 in 2023, then jumped by 308.51% to 98000000.0 in 2024, then sank by 205.1% to 103000000.0 in 2025, then tumbled by 1289.32% to 1431000000.0 in 2026.
  • The last three Income from Continuing Operations figures came in at 1431000000.0 (Q1 2026), 103000000.0 (Q4 2025), and 181000000.0 (Q3 2025), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Income (Continuing) (Qtr)
1 Teva Pharmaceutical Industries 38.34 Bn 34.60 Bn 1.97 Bn 370.00 Mn
2 Zoetis 33.27 Bn 31.33 Bn 1.62 Bn 601.00 Mn
3 United Therapeutics 23.75 Bn 21.60 Bn 648.10 Mn 274.90 Mn
4 Aurora Cannabis 17.11 Bn 17.03 Bn 33.43 Mn 21.05 Mn
5 Neurocrine Biosciences 16.37 Bn 15.05 Bn 800.70 Mn 197.90 Mn
6 Elanco Animal Health 11.78 Bn 11.35 Bn 785.00 Mn 57.00 Mn
7 Alkermes 7.05 Bn 6.54 Bn -116.06 Mn -66.53 Mn
8 Lantheus Holdings 6.49 Bn 5.99 Bn 230.92 Mn 118.42 Mn
9 Hims & Hers Health 6.19 Bn 5.44 Bn 396.79 Mn -92.12 Mn
10 Bausch Health Companies 1.91 Bn 1.58 Bn 2.48 Bn -1.43 Bn

Historic Data

Download Data
DateValue
Mar 31, 2026 -1.43 Bn
Dec 31, 2025 -103.00 Mn
Sep 30, 2025 181.00 Mn
Jun 30, 2025 128.00 Mn
Mar 31, 2025 -86.00 Mn
Dec 31, 2024 98.00 Mn
Sep 30, 2024 -92.00 Mn
Jun 30, 2024 -1.00 Mn
Mar 31, 2024 -77.00 Mn
Dec 31, 2023 -47.00 Mn
Sep 30, 2023 -382.00 Mn
Jun 30, 2023 27.00 Mn
Mar 31, 2023 -209.00 Mn
Dec 31, 2022 -410.00 Mn
Sep 30, 2022 403.00 Mn
Jun 30, 2022 -139.00 Mn
Mar 31, 2022 -66.00 Mn
Dec 31, 2021 72.00 Mn
Sep 30, 2021 191.00 Mn
Jun 30, 2021 -593.00 Mn